{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:57:13Z","timestamp":1768730233044,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1208\/s12249-014-0272-y","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T01:19:57Z","timestamp":1426209597000},"page":"1270-1280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development and Optimization of Gastro-Retentive Controlled-Release Tablet of Calcium-Disodium Edentate and its In Vivo Gamma Scintigraphic Evaluation"],"prefix":"10.1208","volume":"16","author":[{"given":"Neeraj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakuri","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseem","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"key":"272_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(10)60745-3","volume":"376","author":"P Grandjean","year":"2010","unstructured":"Grandjean P. Even low-dose lead exposure is hazardous. Lancet. 2010;376:855\u20136.","journal-title":"Lancet"},{"key":"272_CR2","doi-asserted-by":"crossref","first-page":"s503","DOI":"10.1590\/S0102-311X2008000300004","volume":"24","author":"CJ Passos","year":"2008","unstructured":"Passos CJ, Mergler D. Human mercury exposure and adverse health effects in the Amazon: a review. Cad Saude Publica. 2008;24:s503\u201320.","journal-title":"Cad Saude Publica"},{"key":"272_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1539\/joh.47.1","volume":"47","author":"K Kalia","year":"2005","unstructured":"Kalia K, Flora SJS. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health. 2005;47:1\u201321.","journal-title":"J Occup Health"},{"key":"272_CR4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2011.06.038","volume":"416","author":"N Kumar","year":"2011","unstructured":"Kumar N, Soni S, Jaimini A, Ahmad FJ, Bhatnagar A, Mittal G. Edetate calcium disodium nanoparticle dry powder inhalation: a novel approach against heavy metal decorporation. Int J Pharm. 2011;416:376\u201383.","journal-title":"Int J Pharm"},{"key":"272_CR5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rpd\/ncm473","volume":"127","author":"AC James","year":"2007","unstructured":"James AC, Sasser LB, Stuit DB, Glover SE, Carbaugh EH. Ustur whole body case 0269: demonstrating effectiveness of i.v. Ca-DTPA for Pu. Radiat Prot Dosim. 2007;127:449\u201355.","journal-title":"Radiat Prot Dosim"},{"key":"272_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/oxfordjournals.rpd.a032980","volume":"87","author":"MH Henge-Napoli","year":"2000","unstructured":"Henge-Napoli MH, Stradling GN, Taylor DM. Decorporation of radionuclides from the human body. Radiat Prot Dosim. 2000;87:9\u201317.","journal-title":"Radiat Prot Dosim"},{"key":"272_CR7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1289\/ehp.95103988","volume":"103","author":"RA Goyer","year":"1995","unstructured":"Goyer RA. Chelation of toxic metals: current interests. Environ Health Perspect. 1995;103:988\u20139.","journal-title":"Environ Health Perspect"},{"key":"272_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.HP.0000180771.66884.d3","volume":"90","author":"N Bhardwaj","year":"2006","unstructured":"Bhardwaj N, Bhatnagar A, Pathak DP, Singh AK. Dynamic, equilibrium and human studies of adsorption of 201Tl by Prussian blue. Health Phys. 2006;90:250\u20137.","journal-title":"Health Phys"},{"key":"272_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nano.2008.07.001","volume":"5","author":"R Ali","year":"2009","unstructured":"Ali R, Jain GK, Iqbal Z, Talegaonkar S, Pandit P, Sule S, et al. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote. Nanomedicine: NBM. 2009;5:55\u201363.","journal-title":"Nanomedicine: NBM"},{"key":"272_CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2008.09.018","volume":"71","author":"Bhavna","year":"2009","unstructured":"Bhavna, Ahmad FJ, Mittal G, Jain GK, Malhotra G, Khar RK, et al. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constructive conditions. Eur J Pharm Biopharm. 2009;71:282\u201391.","journal-title":"Eur J Pharm Biopharm"},{"key":"272_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajem.2008.10.025","volume":"28","author":"S Rajpal","year":"2010","unstructured":"Rajpal S, Ali R, Bhatnagar A, Bhandari SS, Mittal G. Clinical and bioavailability studies of sublingually administered atropine sulphate. Am J Emerg Med. 2010;28:143\u201350.","journal-title":"Am J Emerg Med"},{"key":"272_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.etap.2008.10.007","volume":"27","author":"S Rajpal","year":"2009","unstructured":"Rajpal S, Mittal G, Sachdeva R, Chhillar M, Ali R, Agrawal SS, et al. Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers. Environ Toxicol Pharmacol. 2009;27:206\u201311.","journal-title":"Environ Toxicol Pharmacol"},{"key":"272_CR13","unstructured":"The Indian Pharmacopoeia, Indian Pharmacopoeia Commission, Ghaziabad, India 2010."},{"key":"272_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-5173(94)90236-4","volume":"105","author":"M Rosa","year":"1994","unstructured":"Rosa M, Zia H, Rhodes T. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994;105:65\u201370.","journal-title":"Int J Pharm"},{"issue":"2","key":"272_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/2229-4708.84448","volume":"2","author":"S Kambhoj","year":"2011","unstructured":"Kambhoj S, Sharma D, Nair AB, Kamboj S, Sharma RK, Ali J, et al. Simple spectrophotometric method for estimation of disodium edetate in topical gel formulation. Pharm Methods. 2011;2(2):148\u201351.","journal-title":"Pharm Methods"},{"key":"272_CR16","unstructured":"International Conference on Harmonization (ICH). Text on validation of analytical procedures; definition and terminology, vol. 60, US FDA Federal Register; 1995."},{"key":"272_CR17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.2600561005","volume":"56","author":"M Gibaldi","year":"1967","unstructured":"Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations\u2014theoretical considerations and application to non-disintegrating dosage forms. J Pharm Sci. 1967;56:1238\u201342.","journal-title":"J Pharm Sci"},{"key":"272_CR18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jps.2600581021","volume":"58","author":"JG Wagner","year":"1969","unstructured":"Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 1969;58:1253\u20137.","journal-title":"J Pharm Sci"},{"key":"272_CR19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","volume":"52","author":"T Higuchi","year":"1963","unstructured":"Higuchi T. Mechanism of sustained action medications. J Pharm Sci. 1963;52:1145\u20139.","journal-title":"J Pharm Sci"},{"key":"272_CR20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25\u201335.","journal-title":"Int J Pharm"},{"key":"272_CR21","first-page":"110","volume":"60","author":"NA Peppas","year":"1985","unstructured":"Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110\u20131.","journal-title":"Pharm Acta Helv"},{"key":"272_CR22","unstructured":"Mittal G, Singh T, Goomer NC, Bhatnagar A, Lulla A, Malhotra G, et al. Formulations and methods thereof for making radiolabeled dry powder. 2008; Patent No. 1536\/DEL\/2008."},{"key":"272_CR23","first-page":"292","volume":"2","author":"AK Singh","year":"2003","unstructured":"Singh AK, Verma J, Bhatnagar A, Sen S, Bose M. Tc-99m isoniazid: a specific agent for diagnosis of tuberculosis. World J Nucl Med. 2003;2:292\u2013305.","journal-title":"World J Nucl Med"},{"key":"272_CR24","volume-title":"Therapeutic drugs","author":"C Dollery","year":"1999","unstructured":"Dollery C. Therapeutic drugs, vol. 1. 2nd ed. Edinburgh: Churchill Livingstone; 1999.","edition":"2"},{"issue":"1\u20132","key":"272_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2012.04.073","volume":"432","author":"LA Hodges","year":"2012","unstructured":"Hodges LA, Connolly SM, Winter J, Schmidt T, Stevens HN, Hayward M, et al. Modulation of gastric pH by a buffered soluble effervescent formulation: a possible means of improving gastric tolerability of alendronate. Int J Pharm. 2012;432(1\u20132):57\u201362.","journal-title":"Int J Pharm"},{"key":"272_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2008.10.021","volume":"36","author":"A Virid\u00e9na","year":"2009","unstructured":"Virid\u00e9na A, Wittgrenb B, Larsson A. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur J Pharm Sci. 2009;36:297\u2013309.","journal-title":"Eur J Pharm Sci"},{"key":"272_CR27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/jps.2600841213","volume":"84","author":"RTC Ju","year":"1995","unstructured":"Ju RTC, Nixon PR, Patel MV. Drug release from hydrophilic matrixes: new scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci. 1995;84:1455\u201363.","journal-title":"J Pharm Sci"},{"key":"272_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1974.tb00234.x","volume":"1","author":"LF Prescott","year":"1974","unstructured":"Prescott LF. Gastric emptying and drug absorption. Br J Clin Pharmacol. 1974;1:189\u201390.","journal-title":"Br J Clin Pharmacol"},{"key":"272_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2009.11.010","volume":"74","author":"MI Tadros","year":"2010","unstructured":"Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro\u2013in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm. 2010;74:332\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"272_CR30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(99)00204-7","volume":"63","author":"BM Singh","year":"2000","unstructured":"Singh BM, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235\u201359.","journal-title":"J Control Release"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0272-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0272-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:33:21Z","timestamp":1559604801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0272-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0272-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]}}}